My SRS Portfolio Dec 2022

My SRS Portfolio and Thoughts [Dec 2022]

by with No Comment Investment AccumulationSRSTaxes

Congratulations for clearing 2022! 2023 just started. I’ve a good feeling that this year will good to my SRS portfolio. If you need a quick recap, check out my top article for Dec 2022: what happen to the stock market from 2019 to 2022.

Again, if you are new to SRS, please start here.

Disclaimer: This article is not and should not be taken as a buy/sell/hold recommendation.

My SRS Portfolio Dec 2022
My SRS Portfolio Dec 2022

My Thoughts and Consideration

SRS Portfolio Tracker Dec 2022
SRS Portfolio Tracker Dec 2022

SGX:HST looks like it is finally recovering. I believe this is because China is reopening on 8 Jan 2023. They are more relax when it comes to COVID-19 testing and seems like lockdowns will be unlikely. China will be living with COVID-19. While I expect there will be short-term COVID-19 spikes and some disruptions, productivity will pick up soon after. Currently, there is no intention to add more position into SGX:HST.

SGX: BTOU is the most disappointing position in the portfolio. While Manulife  have pivoted and shifted into hotelised buildings and provide flex office solutions, there are several concerns to that SGX: BTOU have to address.

I believe there will be some divesting to reduce aggregate leverage in the next few quarters. Overall, these are all bad news to SGX: BTOU. Therefore, there will be no second entry into SGX: BTOU.

SGX: ME8U is a new entry into the SRS portfolio. I have receive first dividend payout from it and looking forward to the further dividends to come.

I have also embarked into dollar cost averaging into the S&P500. More to be added into this space in the articles to come.

Final Thoughts

It isn’t all sunshine for sure. Take care and hope you are well.

Chengkok is a licensed Financial Services Consultant since 2012. He is an Investment and Critical Illness Specialist. Wealthdojo was created in 2019 to educate and debunk “free financial advice” that was given without context.  

Feel Free To Reach Out To Share Your Thoughts.

Contact: 94316449 (Whatsapp) chengkokoh@gmail.com (Email)
Telegram: Wealthdojo [Continuous Learning Channel]
Reviews: About Me

The views and opinions expressed in this publication are those of the author and do not reflect the official policy or position of any other agency, organisation, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author.

My SRS Portfolio Sept 2022

My SRS Portfolio and Thoughts [Sept 2022]

by with No Comment Investment AccumulationSRS

If you are in cash this year, you would have beaten the market. Congratulations! However, this does not mean you should keep your money as cash as inflation will erode the value of your money.

2022 is a rough year for the investment market. If you have invested in the STI for the past 1 year, you would have achieve no movement at all.

STI ETF Since March 2022
STI ETF Since March 2022

If you have invested in other markets, then you are most likely seeing a red in your portfolio.

If you are new to Supplementary Retirement Sum (SRS), please start here.

Disclaimer: This article is not and should not be taken as a buy/sell/hold recommendation.

My SRS Portfolio Sept 2022
My SRS Portfolio Sept 2022

My Thoughts and Consideration

My SRS Portfolio Sept 2022
My SRS Portfolio Sept 2022

SGX:HST continues to face downward pressure as Beijing’s zero-Covid pursuit, regulatory crackdowns and tensions with the West have led to a US$5 trillion rout in Chinese stocks since early 2021. I have averaged down (why DCA is not working on China’s stocks?) once in March 2022 and will be having a hold approach for this counter for now.

SGX: BTOU slides even further in the last quarter. I believe the main reason is because the FED has raise interest rates to combat inflation. This has made borrowing more expensive and may be a cause of concern for investors. However, it is worth noting the Fixed Rates Loans makes up 85.7% of their debt profile as of 30 June 2022 and isn’t a great cause of concern. BTOU is in a midst of transformation as explained in June 2022. I will be reading closely to this in the quarters ahead.

Manulife US REIT BTOU Debt Profile June 2022
Manulife US REIT BTOU Debt Profile June 2022

SGX: ME8U is a new entry into the SRS portfolio. I was eyeing Mapletree Industrial Trust for a long time. It was a stock that I was interested in even before COVID-19. MIT’s property portfolio comprises of 143 properties ranging from light industrial buildings, stack-up buildings, flatted factories, business park buildings, Hi-Tech building and recently data centers.

Mapletree Industrial Trust portfolio growth in IPO has been amazing with a new position into Data Centre. Looking forward to its’ performance in the years to come.

Mapletree Industrial Trust Portfolio May 2022
Mapletree Industrial Trust Portfolio May 2022

I have also invested a small amount into a 3 year endowment with a guaranteed of 3%. As this is a very straightforward proposition, I will not be updating this particular segment.

Final Thoughts

Quarter 4 is the best time of the year to think about SRS contribution. The main reason for SRS contribution is to reduce your tax payable for your FY2022. You then need to consider the investment portion thereafter. I will be running a webinar on SRS tax reduction in the months ahead.

Do comment below and I will individually send you an invite for the event.

Meanwhile, take care and hope you are well.

Chengkok is a licensed Financial Services Consultant since 2012. He is an Investment and Critical Illness Specialist. Wealthdojo was created in 2019 to educate and debunk “free financial advice” that was given without context.  

Feel Free To Reach Out To Share Your Thoughts.

Contact: 94316449 (Whatsapp) chengkokoh@gmail.com (Email)
Telegram: Wealthdojo [Continuous Learning Channel]
Reviews: About Me

The views and opinions expressed in this publication are those of the author and do not reflect the official policy or position of any other agency, organisation, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author.

My SRS Portfolio June 2022

My SRS Portfolio and Thoughts [June 2022]

by with No Comment Investment AccumulationMoney MindsetPersonal FinanceSRS
My SRS Portfolio June 2022
My SRS Portfolio June 2022

I’m writing this in the middle of June as I’ll be busy preparing for reservist during month end. In addition to the perfect long storm, inflation has been coming up in all areas. We are also officially in the bear market [Read More: Bear Market Survival Guide]. I have also finally added my position using dollar cost averaging which I will be covering more below.

If you are new to Supplementary Retirement Sum (SRS), please start here.

Disclaimer: This article is not and should not be taken as a buy/sell/hold recommendation.

My Thoughts and Consideration

My SRS Portfolio and Thoughts June 2022
My SRS Portfolio and Thoughts June 2022

Other than the new pie chart, I have added more into SGX: HST. The new addition is a very simple dollar cost averaging move. In China, Chinese banks cut a key interest rate for long-term loans. This can be seen as a bullish move as this will boost loan demand. However, China still struggles with lock-down from time to time if COVID cases were to arise. Let’s see how it turns out.

Meanwhile in SGX: BTOU, William David Gantt is appointed as the new CEO. Gantt wants to build a higher proportion of growth tenants, and this will be done through capital recycling, not acquisitions, for now. Their new focus will be on building quality income instead of growth. We probably will be looking at a new tenant mix in the quarters to come. I believe that the US office space is having an identity crisis now as working from home is a choice for employees now. If every company start to behave like Tesla (remote work privilege to end), we will see a higher occupational rates in the quarters to come.

I probably will be looking at a few Singapore companies in the quartiers to come.

Final Thoughts

I reemphasize again that this is not and should not be taken as a buy/sell recommendation. Wishing you all the best!

 

Chengkok is a licensed Financial Services Consultant since 2012. He is an Investment and Critical Illness Specialist. Wealthdojo was created in 2019 to educate and debunk “free financial advice” that was given without context.  

Feel Free To Reach Out To Share Your Thoughts.

Contact: 94316449 (Whatsapp) chengkokoh@gmail.com (Email)
Telegram: Wealthdojo [Continuous Learning Channel]
Reviews: About Me

The views and opinions expressed in this publication are those of the author and do not reflect the official policy or position of any other agency, organisation, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author.

My SRS Portfolio March 2022

My SRS Portfolio and Thoughts [March 2022]

by with One Comment Investment AccumulationPersonal FinanceSRS
My SRS Portfolio March 2021
My SRS Portfolio March 2022

What an epic start to 2022. In just one quarter we are now in the amidst of the Perfect Long Storm, Russian-Ukraine Tension and Will Smith slapping Chris Rock. Maybe the saving grace is that we will be able to travel to Malaysia (with more freedom) from 1st April.

In any case, this is the SRS update for March 2022. If you are new to SRS, I would encourage you to start from my most read SRS article, 5 Things You Need To Know About SRS to begin.

Disclaimer: This is not and should not be taken as a buy/sell recommendation.

My Thoughts And Consideration

My SRS Portfolio and Thoughts [March 2022]
My SRS Portfolio and Thoughts [March 2022]
The most glaring underperformance continues to be my exposure into Chinese Technology Stocks (SGX:HST). The price is already 41% down since the last time I entered. The question I get asked frequently is how will China do moving ahead.

According to Political Bureau of the Communist Party of China (CPC) Central Committee meeting on Dec 2021, the focus on 2022 will be prioritize stability while pursuing progress. This is a great difference from their focus of strengthening antimonopoly rules in 2021. I believe this might be a turning point and am considering a Dollar Cost Averaging into SGX:HST. This is after a capital injection into the SRS for tax purpose.

Final Thoughts

I reemphasize again that this is not and should not be taken as a buy/sell recommendation. Wishing you all the best!

 

Chengkok is a licensed Financial Services Consultant since 2012. He is an Investment and Critical Illness Specialist. Wealthdojo was created in 2019 to educate and debunk “free financial advice” that was given without context.  

Feel Free To Reach Out To Share Your Thoughts.

Contact: 94316449 (Whatsapp) chengkokoh@gmail.com (Email)
Telegram: Wealthdojo [Continuous Learning Channel]
Reviews: About Me

The views and opinions expressed in this publication are those of the author and do not reflect the official policy or position of any other agency, organisation, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author.

My SRS Portfolio Dec 2021

My SRS Portfolio and Thoughts [Dec 2021]

by with No Comment Self Directed InvestingSRSStock Analysis
My SRS Portfolio Dec 2021
My SRS Portfolio Dec 2021

Welcome to 2022! 2021 has been a year of burn outs, huge volatility and filled with epic events. I sincerely hope that everyone is well and charged up for a fresh start! In any case, this article is a simple reporting for my SRS updates.

Disclaimers: This is not and should not be taken as a buy/sell recommendation.

If you are new to SRS, I would encourage you to start from my most read SRS article, 5 Things You Need To Know About SRS to begin.

My Thoughts And Consideration

My SRS Portfolio Performance Dec 2021
My SRS Portfolio Performance Dec 2021

SGX:HST (Lion-OCBC Sec HSTECH S$)

The performance is not pretty. The elephant in the room continues to be my exposure into Chinese Technology Stocks (SGX:HST). You can read why I like SGX:HST in March2021 review. It continues to drag the portfolio down despite good fundamentals.

I continue to be positive in this exposure as this ETF is invested into quality Chinese companies that can deliver sustainable growth in the next 3 to 5 years. The undervalued sector has attracted Charlie Munger who has double down in to Alibaba. I have no doubt that the companies in this sector will do well and eventually the share price will follow.

SGX: BTOU (Manulife US REIT)

I first bought into SGX: BTOU as a recovery value play in the portfolio in March2021. However, things changed for BTOU as they pivoted from investing only in Class-A and Trophy assets in the traditional gateway city offices to Sun Belt states and emerging markets.

If I can create a Singapore reference, this REIT invest only into MBFC or One Raffles Place previously and are now investing into “emerging” locations like International Business Park at Jurong East or Woods Square at Woodlands. This is not a perfect reference and I hope you get the idea.

Generally, I like it when companies use data to look at emerging trends and are flexible to adapt to their new strategy. ProButtery wrote a very comprehensive article on BTOU and I very much agree with his thesis. You can find his thoughts here.

I look forward their future business performance.

Lastly, I added new capital into my SRS account for tax purposes. .

Final Thoughts

Disclaimer: this is not and should not be taken as a buy/sell recommendation. Like what Charlie Munger famously said: the big money is not in the buying or selling.. but in the waiting.

 

Chengkok is a licensed Financial Services Consultant since 2012. He is an Investment and Critical Illness Specialist. Wealthdojo was created in 2019 to educate and debunk “free financial advice” that was given without context.  

Feel Free To Reach Out To Share Your Thoughts.

Contact: 94316449 (Whatsapp) chengkokoh@gmail.com (Email)
Telegram: Wealthdojo [Continuous Learning Channel]
Reviews: About Me

The views and opinions expressed in this publication are those of the author and do not reflect the official policy or position of any other agency, organisation, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author.